How J&J Scientist Koul Hopes To Reboot R&D At India’s IMTECH

Anil Koul, part of the Johnson & Johnson team that discovered and developed TB drug Sirturo, is currently on a sabbatical to head up IMTECH, an Indian R&D institute. Koul shares with Scrip the ups and downs of Sirturo's development journey and outlines what he hopes to achieve at IMTECH.

Anil Koul
J&J's Dr. Anil Koul takes on a new challenge in India

More from Anti-infective

More from Therapy Areas